Four years after the COVID-19 pandemic shook the world, Indonesia continues to prioritize vaccination as a crucial measure to protect public health. The outbreak began in late 2019, with news of the coronavirus spreading from China. By early 2020, the virus had reached Indonesia, drastically changing daily life. Schools closed, workplaces shifted to remote systems (WFH), and online learning became the new norm.
The Ministry of Health faced significant challenges as the public panicked, stockpiling masks, gloves, and essential goods. Various vaccines, including Sinovac, Bio Farma, AstraZeneca, Sinopharm, Moderna, and Pfizer, were introduced to curb the virus's spread. These efforts successfully paved the way for Indonesia to transition into the "New Normal," emphasizing the continued importance of vaccination.
However, in 2024, with COVID-19 now classified as an endemic disease, vaccination remains relevant and essential. As of 1 January 2024, the COVID-19 vaccine has officially become part of the national routine immunization program.
This program targets two main groups: individuals who have never been vaccinated and those who have received at least one dose. Special attention is given to vulnerable populations such as the elderly, individuals with comorbidities, pregnant women, teenagers, and healthcare workers, all of whom receive free COVID-19 vaccinations.
The program aims not only to protect individuals but also to prevent case surges and build community resilience. Integrating COVID-19 vaccines into routine immunization reflects Indonesia's commitment to the Sustainable Development Goals (SDGs), particularly Goal 4, which emphasizes the importance of quality education, including health education.
In Yogyakarta, health authorities and the academic community of the Faculty of Dentistry at Universitas Gadjah Mada (FKG UGM) play an active role in vaccination education and promotion. Healthcare professionals conduct outreach programs in schools, communities, and health centers to provide accurate information about vaccine benefits. These efforts aim to raise public awareness and combat misinformation about COVID-19 vaccines.
Through these measures, Indonesia continues to demonstrate its commitment to protecting public health. Vaccination remains a key element in maintaining national resilience against COVID-19. By focusing on health education and ensuring widespread vaccine availability, the government and the community can work together to build a healthier and more resilient society.
Authors: Firda Cahya & Pram
